Pleural Neoplasms

"Pleural Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.

Descriptor ID	D010997
MeSH Number(s)	C04.588.894.797.640 C08.528.694 C08.785.640
Concept/Terms	Pleural Neoplasms Pleural Neoplasms Neoplasms, Pleural Neoplasm, Pleural Pleural Neoplasm

Below are MeSH descriptors whose meaning is more general than "Pleural Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Thoracic Neoplasms [C04.588.894]
Respiratory Tract Neoplasms [C04.588.894.797]
Pleural Neoplasms [C04.588.894.797.640]
Respiratory Tract Diseases [C08]
Pleural Diseases [C08.528]
Pleural Neoplasms [C08.528.694]
Respiratory Tract Neoplasms [C08.785]
Pleural Neoplasms [C08.785.640]

Below are MeSH descriptors whose meaning is related to "Pleural Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Pleural Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pleural Neoplasms" by people in this website by year, and whether "Pleural Neoplasms" was a major or minor topic of these publications.

Bar chart showing 14 publications over 9 distinct years, with a maximum of 3 publications in 2011 and 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2006	1	0	1
2007	2	0	2
2010	1	0	1
2011	2	1	3
2012	3	0	3
2014	1	0	1
2021	0	1	1
2025	1	0	1

Below are the most recent publications written about "Pleural Neoplasms" by people in Profiles.

Poulos CM, Servais EL. Precision Medicine in Thoracic Surgery: Chest Wall, Pleural, and Mediastinal Malignancies. Thorac Surg Clin. 2025 Nov; 35(4):461-468.

View in: PubMed
Sehgal K, Gill RR, Widick P, Bindal P, McDonald DC, Shea M, Rangachari D, Costa DB. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy. JAMA Netw Open. 2021 02 01; 4(2):e2037120.

View in: PubMed
Adusumilli PS, Cherkassky L, Villena-Vargas J, Colovos C, Servais E, Plotkin J, Jones DR, Sadelain M. Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity. Sci Transl Med. 2014 Nov 05; 6(261):261ra151.

View in: PubMed
Kruse M, Sherry SJ, Paidpally V, Mercier G, Subramaniam RM. FDG PET/CT in the management of primary pleural tumors and pleural metastases. AJR Am J Roentgenol. 2013 Aug; 201(2):W215-26.

View in: PubMed
Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013 May; 137(5):647-67.

View in: PubMed
Servais EL, Colovos C, Rodriguez L, Bograd AJ, Nitadori J, Sima C, Rusch VW, Sadelain M, Adusumilli PS. Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients. Clin Cancer Res. 2012 May 01; 18(9):2478-89.

View in: PubMed
Sheff KW, Hoda MA, Dome B, Hegedus B, Klepetko W, Weiss GJ. The role of microRNAs in the diagnosis and treatment of malignant pleural mesothelioma--a short review. Microrna. 2012; 1(1):40-8.

View in: PubMed
Servais EL, Suzuki K, Colovos C, Rodriguez L, Sima C, Fleisher M, Rusch VW, Sadelain M, Adusumilli PS. An in vivo platform for tumor biomarker assessment. PLoS One. 2011; 6(10):e26722.

View in: PubMed
Servais EL, Colovos C, Kachala SS, Adusumilli PS. Pre-clinical mouse models of primary and metastatic pleural cancers of the lung and breast and the use of bioluminescent imaging to monitor pleural tumor burden. Curr Protoc Pharmacol. 2011 Sep; Chapter 14:Unit14.21.

View in: PubMed
Shi M, Fraire AE, Chu P, Cornejo K, Woda BA, Dresser K, Rock KL, Jiang Z. Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation. Am J Surg Pathol. 2011 Jun; 35(6):878-82.

View in: PubMed

People

Explore

Similar Concepts

Top Journals